High Outlier
Strength
24 ug/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764024060
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
LUBIPROSTONEApproval Type
New Drug (NDA)
FDA Application
NDA021908On Market Since
1/31/2006
Pharmacological Classes
Chloride Channel Activator
Chloride Channel Activators
Related Drugs
Same classification
No related drugs found.